Osteoprotegerin (OPG) contains a cysteine-rich domain, a transmembrane domain, and a TNF receptor-like domain. This structure allows it to bind to and inhibit the activity of receptor activator of nuclear factor-kappa B ligand (RANKL).

ELISA kit information:

• Reactivity: Human
• Sample Type: Serum, Tissue Homogenates, Plasma, Biological Fluids
• Sensitivity: 37.5 pg/ml
• Target: Osteoprotegerin, OPG, Osteoclastogenesis Inhibitory Factor, TR1, TNFRSF11B